Stem cells petri dish

Stem cells are undifferentiated cells that can differentiate into various cell types, forming the basis of regenerative medicine and advanced research.

About this subject

Stem cells are unspecialized cells capable of self-renewal and differentiation into various cell lineages. They are classified into embryonic (pluripotent), adult (multipotent), and induced pluripotent stem cells (iPS), the latter created in the lab from somatic cells. Shinya Yamanaka's discovery of iPS cells in 2006 earned the Nobel Prize in Medicine in 2012 and bypassed ethical concerns associated with embryonic cells.

Clinically, hematopoietic stem cell transplantation from bone marrow is standard for leukemia and lymphoma. In research, stem cells model diseases such as Parkinson's, type 1 diabetes, and amyotrophic lateral sclerosis, and are used for drug testing. Recent advances include organoids, mini-organs grown from stem cells that mimic tissues for study.

Technical challenges include precise differentiation control and the risk of teratoma formation. In Brazil, the Biosafety Law (2005) permits research with nonviable embryos, a middle ground in the global ethical debate. Institutions like USP, Unicamp, and Instituto Butantan conduct relevant research, contributing to therapeutic progress.

Frequently Asked Questions

What are stem cells?

Stem cells are unspecialized cells capable of self-renewal and differentiation into multiple cell types, such as neurons, heart cells, or muscle cells.

What are the main types of stem cells?

The main types are embryonic (pluripotent), adult (multipotent), and induced pluripotent stem cells (iPS), created in the lab from adult cells.

Which diseases can be treated with stem cells?

Hematopoietic stem cell transplants treat leukemias and lymphomas. Research is advancing for Parkinson's, type 1 diabetes, spinal cord injuries, and macular degeneration.